Azenta, Inc.
Azenta, Inc. provides life science sample exploration and management solutions for the life sciences market in North America, Europe, China, the Asia Pacific, and internationally. The company operates through two reportable segments, Life Sciences Produc…
Medical - Instruments & Supplies
US, Chelmsford [HQ]
Financials
Analysts
Wall Street · Earnings · Institutional SentimentA comprehensive analysis section that covers unveiling insights about Azenta, Inc.'s gradings, price targets and earnings estimates. None
| FY | EPS | Revenue [mil.] | Profit [mil.] | EBITDA [mil.] | EBIT [mil.] | Expenses · SGA [mil.] | ||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| E | E | E | E | E | E | |||||||
| 2015 | 0.2100 | 0.408 | 552 | 550 | 14 | 27 | 48 | 52 | 21 | 0.24 | 115 | 215 |
| 2016 | -1.0100 | 0.404 | 560 | 551 | -69 | 26 | 44 | 53 | 16 | 0.24 | 130 | 216 |
| 2017 | 0.9000 | 1.178 | 692 | 685 | 62 | 78 | 97 | 65 | 67 | 0.30 | 153 | 268 |
| 2018 | 1.6500 | 1.550 | 631 | 825 | 116 | 102 | 68 | 79 | 32 | 0.36 | 167 | 323 |
| 2019 | 0.1400 | 0.764 | 781 | 777 | 9 | 50 | 102 | 74 | 48 | 0.34 | 211 | 304 |
| 2020 | 0.8800 | 1.151 | 897 | 885 | 64 | 76 | 144 | 85 | 79 | 0.39 | 241 | 346 |
| 2021 | -0.3900 | 2.531 | 513 | 1,188 | -28 | 167 | 18 | 114 | -30 | 0.52 | 252 | 465 |
| 2022 | -0.1500 | 0.424 | 555 | 551 | -11 | 28 | 49 | 53 | -24 | 0.24 | 252 | 216 |
| 2023 | -0.2200 | 0.203 | 665 | 656 | -14 | 13 | 41 | 63 | -87 | 0.29 | 316 | 257 |
| 2024 | - | 0.334 | - | 655 | - | 22 | - | 63 | - | 0.29 | - | 256 |
| 2025 | - | 0.417 | - | 697 | - | 27 | - | 67 | - | 0.30 | - | 273 |
| 2026 | - | 1.F11X/td> | - | 1.F11X/td> | - | 1.F11X/td> | - | 1.F111/td> | - | 1.F111 | - | 1.F111 |
| 2027 | - | 0.F12X/td> | - | 0.F12X/td> | - | 0.F12X/td> | - | 0.F121/td> | - | 0.F121 | - | 0.F121 |